D. Shochat

发表

Comparative immunological study of albumins of Anolis lizards of the Caribbean islands

H. Dessauer, D. Shochat, 1981 .

Characterization of two metastatic subpopulations originating from a single human colon carcinoma.

D. Dexter, D. Gold, D. Shochat, 1983, Cancer research.

N-Succinyl-(beta-alanyl-L-leucyl-L-alanyl-L-leucyl)doxorubicin: an extracellularly tumor-activated prodrug devoid of intravenous acute toxicity.

D. Shochat, V. Dubois, A. Trouet, 2001, Journal of medicinal chemistry.

A calicheamicin conjugate with a fully humanized anti-MUC1 antibody shows potent antitumor effects in breast and ovarian tumor xenografts.

A. Mountain, C. Beyer, D. Shochat, 2005, Bioconjugate chemistry.

CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity.

G. Yarranton, D. Shochat, V. Dubois, 2002, Cancer research.

Studies on the structure of the organ-specific determinant of human colonic mucin.

D. Gold, D. Shochat, 1989, Molecular immunology.

Imaging of primary and metastatic liver cancer with 131I monoclonal and polyclonal antibodies against alphafetoprotein.

E. Ruoslahti, D. Goldenberg, D. Shochat, 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Potentiation of Antiproliferative Effects of Monoclonal Antibody Lym‐1 and Immunoconjugate Lym‐1‐gelonin on Human Burkitt's Lymphoma Cells with γ‐Interferon and Tumor Necrosis Factor

B. Diamond, M. Rosenblum, J. Dutcher, 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinoma.

H. Groen, L. de Leij, E. Smit, 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Colon‐specific antigen‐p (CSAp). I: Initial clinical evaluation as a marker for colorectal cancer

D. Goldenberg, D. Shochat, K. D. Pant, 1982 .

Comparison of tumor targeting of mouse monoclonal and goat polyclonal antibodies to carcinoembryonic antigen in the GW-39 human tumor-hamster host model.

D. Goldenberg, R. Sharkey, F. J. Primus, 1988, Cancer research.

Dose fractionation of radiolabeled antibodies in patients with metastatic colon cancer.

J. Schlom, R. Meredith, R. Wheeler, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Experimental studies of tumor radioimmunodetection using antibody mixtures against carcinoembryonic antigen (CEA) and colon‐specific antigen‐p (CSAp)

S. Gaffar, D. Goldenberg, S. Bennett, 1981, International journal of cancer.

CPI-0004 Na , a New Extracellularly Tumor-Activated Prodrug of Doxorubicin : In Vivo Toxicity , Activity , and Tissue Distribution Confirm Tumor Cell Selectivity 1

G. Yarranton, D. Shochat, V. Dubois, 2002 .

A rapid colorimetric assay for the estimation of microgram quantities of DNA.

D. Gold, D. Shochat, David V. Gold, 1980, Analytical biochemistry.

Comparison of diagnostic and therapeutic doses of 131I-LYM-1 in patients with non-Hodgkin's lymphoma

R. Meredith, R. Wheeler, A. Lobuglio, 1993 .

A phase I escalating-dose safety, dosimetry and efficacy study of radiolabeled monoclonal antibody LYM-1.

A. M. Zimmer, T. Kuzel, S. Rosen, 1993, Cancer biotherapy.

Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxorubicin and preliminary in vitro and in vivo studies.

J. Abarca-Quinones, D. Shochat, V. Dubois, 2001, Cancer research.

Differential expression of tumor-associated antigens in human colon carcinomas xenografted into nude mice.

D. Goldenberg, D. Dexter, F. J. Primus, 1983, Journal of the National Cancer Institute.

Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia.

Irwin Hollander, I. Bernstein, H. Tsou, 2002, Bioconjugate chemistry.

Radioimmunotherapy of colorectal carcinoma xenografts in nude mice with yttrium-90 A33 IgG and Tri-Fab (TFM).

J. Humm, L. Old, S. Welt, 1996, British Journal of Cancer.

Protease digestion of colonic mucin. Evidence for the existence of two immunochemically distinct mucins.

D. Gold, D. Shochat, F. Miller, 1981, The Journal of biological chemistry.

Abstracts of papers and posters Meeting on Pharmaceutical Sciences

S. W. F. Omta, Gert Luurtsema, John Urquhart, 1993, Pharmacy World and Science.

The identification of epitopic sites in human α1-proteinase inhibitor

D. Shochat, S. Chan, M. Jarrells, 1987 .

Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.

I. Bernstein, I. Bernstein, J. Eary, 1996, Cancer research.

Representation of epitopes on colon-specific antigen-p defined by monoclonal antibodies.

D. Goldenberg, F. J. Primus, D. Shochat, 1987, Journal of the National Cancer Institute.

Advances in Brief Extracellularly Tumor-activated Prodrugs for the Selective Chemotherapy of Cancer : Application to Doxorubicin and Preliminary in Vitro and in Vivo Studies 1

J. Abarca-Quinones, D. Shochat, V. Dubois, 2001 .

Organ specific antigens of the human gastrointestinal tract.

D. Gold, D. Shochat, G. Ishizaki, 1986, Molecular immunology.

Characterization of colon-specific antigen-p and isolation of immunologically active tryptic peptides.

D. Goldenberg, D. Gold, D. Shochat, 1981, Journal of immunology.

Purification and characterization of carcinoembryonic antigen from GW-39, a xenografted human colonic tumor system.

D. Goldenberg, D. Shochat, Y. Tu, 1988, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans.

J. Schlom, R. Meredith, R. Wheeler, 1991, Cancer research.

Phase I trial of iodine-131-chimeric B72.3 (human IgG4) in metastatic colorectal cancer.

J. Schlom, R. Meredith, R. Wheeler, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Colon‐specific antigen‐p (CSAp). II: Further characterization in colorectal and pancreatic cancer

D. Goldenberg, D. Shochat, K. D. Pant, 1982, Cancer.